Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GATX CORPGATX · Entity 2783 | EVP, General Counsel & Secy. | February 23, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GATX CORP
Report date February 23, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2026 NQ Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $196.40 · Expires 2033-02-23 | Direct | 7,100 |
Reported balance
After 2026-02-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-23 · Grant · Acquired 7,100 · Balance 7,100 F1: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant. |
| Common StockSEC Table I · non-derivative | Direct | 7,041 |
Reported balance
Holding disclosure · report date 2026-02-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,041 |
Filing footnotes · ownership attribution and instrument terms
F1: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 25, 2026 23:54 UTC | GATX CORP GATX · Entity 2783 | Grant2026 NQ Stock Option (Right to Buy) · Derivative | 7,100 | $0.00 Strike: $196.40 | $0.00 |
DisclosureSEC source: 0001956917-26-000008 · primarydocument.xml · derivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,100 Underlying: Common Stock · 7,100 shares Expires 2033-02-23 F1 · derivative.exercise_date: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:50 UTC | GATX CORP GATX · Entity 2783 | Exercise / conversion2020 NQ Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001956917-26-000007 · primarydocument.xml · derivative · entry 4 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:50 UTC | GATX CORP GATX · Entity 2783 | SaleCommon Stock | 874 | $198.61 | $173,585.23 |
DisclosureSEC source: 0001956917-26-000007 · primarydocument.xml · nonDerivative · entry 3 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,041 F2 · price: Represents the weighted average sale price. The highest price at which shares were sold was $198.9012 and the lowest price at which shares were sold was $198.2825. Information regarding the number of shares sold at each separate price will be made available from the reporting person upon request by the SEC, the issuer or its shareholders. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:50 UTC | GATX CORP GATX · Entity 2783 | SaleCommon Stock | 1,126 | $198.04 | $222,998.56 |
DisclosureSEC source: 0001956917-26-000007 · primarydocument.xml · nonDerivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,915 F1 · price: Represents the weighted average sale price. The highest price at which shares were sold was $198.2250 and the lowest price at which shares were sold was $197.2700. Information regarding the number of shares sold at each separate price will be made available from the reporting person upon request by the SEC, the issuer or its shareholders. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:50 UTC | GATX CORP GATX · Entity 2783 | Exercise / conversionCommon Stock | 2,000 | $77.07 | $154,140.00 |
DisclosureSEC source: 0001956917-26-000007 · primarydocument.xml · nonDerivative · entry 1 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 18:41 UTC | GATX CORP GATX · Entity 2783 | Tax withholdingCommon Stock | 1,236 | $192.83 | $238,331.70 |
DisclosureSEC source: 0001956917-26-000005 · primarydocument.xml · nonDerivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,041 Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 18:41 UTC | GATX CORP GATX · Entity 2783 | GrantCommon Stock | 2,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001956917-26-000005 · primarydocument.xml · nonDerivative · entry 1 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,277 Read SEC document |
| January 30, 2025 Filed Feb 1, 2025 02:56 UTC | GATX CORP GATX · Entity 2783 | Grant2025 NQ Stock Option (Right to Buy) · Derivative | 6,200 | $0.00 Strike: $166.19 | $0.00 |
DisclosureSEC source: 0001562180-25-000760 · primarydocument.xml · derivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,200 Underlying: Common Stock · 6,200 shares Expires 2032-01-30 F1 · derivative.exercise_date: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:31 UTC | GATX CORP GATX · Entity 2783 | Tax withholdingCommon Stock | 258 | $165.15 | $42,608.70 |
DisclosureSEC source: 0001562180-25-000707 · primarydocument.xml · nonDerivative · entry 1 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,406 Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 18:44 UTC | GATX CORP GATX · Entity 2783 | Tax withholdingCommon Stock | 343 | $126.80 | $43,492.40 |
DisclosureSEC source: 0001562180-24-000838 · primarydocument.xml · nonDerivative · entry 1 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,578 Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 20:14 UTC | GATX CORP GATX · Entity 2783 | Grant2024 NQ Stock Option (Right to Buy) · Derivative | 6,100 | $0.00 Strike: $126.47 | $0.00 |
DisclosureSEC source: 0001562180-24-000731 · primarydocument.xml · derivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,100 Underlying: Common Stock · 6,100 shares Expires 2031-01-25 F1 · derivative.exercise_date: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:44 UTC | GATX CORP GATX · Entity 2783 | Tax withholdingCommon Stock | 215 | $113.27 | $24,351.98 |
DisclosureSEC source: 0001562180-23-000797 · primarydocument.xml · nonDerivative · entry 1 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833 Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:59 UTC | GATX CORP GATX · Entity 2783 | Grant2023 NQ Stock Option (Right to Buy) · Derivative | 5,600 | $0.00 Strike: $113.28 | $0.00 |
DisclosureSEC source: 0001562180-23-000741 · primarydocument.xml · derivative · entry 2 Glassberg Brian L · CIK 0001956917 · EVP, General Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 Underlying: Common Stock · 5,600 shares Expires 2030-01-26 F1 · derivative.exercise_date: 33.33% of Stock Option granted may be exercised commencing 1 year from the date of the grant, an additional 33.33% commencing 2 years from the date of the grant and the remaining 33.34% commencing 3 years from the date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.